These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2867389)

  • 21. Infertility, megalocystic and polycystic ovaries: differential response to LHRH therapy.
    Tucker M; Adams J; Mason WP; Jacobs HS
    Ups J Med Sci; 1984; 89(1):43-6. PubMed ID: 6377641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
    Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A
    J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Revelation of a polymicrocystic ovary syndrome after one month's treatment by pulsatile GnRH in a patient presenting with functional hypothalamic amenorrhea].
    Reyss AC; Merlen E; Demerle C; Dewailly D
    Gynecol Obstet Fertil; 2003 Dec; 31(12):1039-42. PubMed ID: 14680786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective, randomized comparison between pulsatile GnRH therapy and combined gonadotropin (FSH+LH) treatment for ovulation induction in women with hypothalamic amenorrhea and underlying polycystic ovary syndrome.
    Dubourdieu S; Fréour T; Dessolle L; Barrière P
    Eur J Obstet Gynecol Reprod Biol; 2013 May; 168(1):45-8. PubMed ID: 23298894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjusting the dose to the individual response of the patient during the induction of ovulation with pulsatile gonadotropin-releasing hormone.
    Mais V; Melis GB; Strigini F; Antinori D; de Ruggiero A; Fioretti P
    Fertil Steril; 1991 Jan; 55(1):80-5. PubMed ID: 1898894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovulatory disorders in women with polycystic ovary syndrome.
    Franks S; Adams J; Mason H; Polson D
    Clin Obstet Gynaecol; 1985 Sep; 12(3):605-32. PubMed ID: 3933879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transvaginal ultrasound detection of multifollicular ovaries in non-hirsute ovulatory women.
    Phy J; Foong S; Session D; Thornhill A; Tummon I; Dumesic D
    Ultrasound Obstet Gynecol; 2004 Feb; 23(2):183-7. PubMed ID: 14770401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease.
    Remorgida V; Venturini PL; Anserini P; Salerno E; de Cecco L
    Fertil Steril; 1991 Jan; 55(1):61-5. PubMed ID: 1898892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea.
    Martin KA; Hall JE; Adams JM; Crowley WF
    J Clin Endocrinol Metab; 1993 Jul; 77(1):125-9. PubMed ID: 8325934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome.
    Homburg R; Armar NA; Eshel A; Adams J; Jacobs HS
    BMJ; 1988 Oct; 297(6655):1024-6. PubMed ID: 3142595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of subcutaneous luteinising hormone releasing hormone in the induction of ovulation.
    Mason WP; Adams J; Tucker M; Jacobs HS
    Ups J Med Sci; 1984; 89(1):33-7. PubMed ID: 6377639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycystic ovarian disease unmasked by pulsatile GnRH therapy in a subgroup of women with hypothalamic amenorrhea.
    Mattle V; Bilgyicildirim A; Hadziomerovic D; Ott HW; Zervomanolakis I; Leyendecker G; Wildt L
    Fertil Steril; 2008 Feb; 89(2):404-9. PubMed ID: 17583701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The induction of ovulation using pulsatile luteinizing hormone releasing hormone in clinical practice.
    Ross LD; Robertson G; Milton PJ; Blows R
    Br J Obstet Gynaecol; 1985 Aug; 92(8):815-9. PubMed ID: 3896301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of ovarian activity by pulsatile infusion of LHRH in women with lactational amenorrhoea.
    Glasier A; McNeilly AS; Baird DT
    Clin Endocrinol (Oxf); 1986 Mar; 24(3):243-52. PubMed ID: 3085998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycystic ovaries--a common finding in normal women.
    Polson DW; Adams J; Wadsworth J; Franks S
    Lancet; 1988 Apr; 1(8590):870-2. PubMed ID: 2895373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical effects of pulsatile LH-RH administration on ovulation induction for women with various type of amenorrhea].
    Mizunuma H; Obara M; Yamada K; Ibuki Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Mar; 42(3):253-8. PubMed ID: 2185321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulsatile gonadotrophin releasing hormone stimulation after medium-term pituitary suppression in polycystic ovary syndrome.
    Scheele F; Hompes PG; van der Meer M; Schoute E; Schoemaker J
    Hum Reprod; 1993 Nov; 8 Suppl 2():197-9. PubMed ID: 8276960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uterine growth in the follicular phase of spontaneous ovulatory cycles and during luteinizing hormone-releasing hormone-induced cycles in women with normal or polycystic ovaries.
    Adams JM; Tan SL; Wheeler MJ; Morris DV; Jacobs HS; Franks S
    Fertil Steril; 1988 Jan; 49(1):52-5. PubMed ID: 3275552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrasound assessment of changes in the ovary and the uterus during LHRH therapy.
    Adams J; Mason WP; Tucker M; Morris DV; Jacobs HS
    Ups J Med Sci; 1984; 89(1):39-42. PubMed ID: 6377640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.